Transgenic knockouts as part of high-throughput, evidence-based target selection and validation strategies

Drug Discovery Today

Volumn 6, Issue 12, 2001, Pages 628-636

  Harris, Stephen ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; BIOLOGY; BIOTECHNOLOGY; DRUG INDUSTRY; EVIDENCE BASED MEDICINE; GENE EXPRESSION; GENE SEQUENCE; GENERAL ASPECTS OF DISEASE; GENOME; HUMAN; KNOCKOUT GENE; KNOCKOUT MOUSE; MOLECULAR GENETICS; NONHUMAN; PHENOTYPE; SHORT SURVEY; TRANSGENE; TRANSGENIC ANIMAL; VALIDATION PROCESS;

EID: 0035368874     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)01794-9     Document Type: Review

References (24)

1. Genomic sciences and the medicines of tomorrow
2. Obtaining value from the human genome: a challenge for the pharmaceutical industry
3. Genomics: the race is on
4. Functional genomics: from genes to new therapies
5. Transgenic gene knock-outs: functional genomics and therapeutic target selection
6. Drug discovery: a historical perspective
7. Initial sequencing and analysis of the human genome
8. How to count...human genes
9. Impact of the human genome sequence for in silico target discovery
10. Genomics and intellectual property rights
11. Biomedical discovery with DNA arrays
12. Experimentalism in Proteomics
13. Antisense oligonucleotides: a systematic high-throughput approach to target validation and gene function determination
14. OMIM passes the 1000-disease-gene mark
15. Mouse models of human disease. Part I: techniques and resources for genetic analysis in mice
16. Mouse models of human disease. Part II: recent progress and future directions
17. Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens
18. Current status and use of short/medium term models for carcinogenicity testing of pharmaceuticals - scientific perspective
19. Opioids: first lessons from knockout mice
20. In vivo gene modification elucidates subtype-specific functions of alpha(2)-adrenergic receptors
21. Insight into adenosine receptor function using antisense and gene-knockout approaches
22. Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission
23. Choose your target
24. Disruption and sequence identification of 2000 genes in mouse embryonic stem cells